| Display title | Chemistry:ADB-HEXINACA |
| Default sort key | ADB-HEXINACA |
| Page length (in bytes) | 3,475 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 833849 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>JTerm |
| Date of page creation | 03:14, 6 February 2024 |
| Latest editor | imported>JTerm |
| Date of latest edit | 03:14, 6 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | ADB-HEXINACA (also known as ADB-HINACA and ADMB-HEXINACA) is a cannabinoid designer drug that has been found as an ingredient in some synthetic cannabis products, first appearing in early 2021. It is a longer chain homologue of previously encountered synthetic cannabinoid compounds such as ADB-BUTINACA... |
